Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
Hyperuricemia (HU) and gout are independent risk factors for chronic kidney disease (CKD). Worldwide, the increasing prevalence of CKD leads to a deterioration in the quality and duration of life of patients and an increase in mortality. If HU plays a significant role in the development of renal fai...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA-PRESS LLC
2024-10-01
|
| Col·lecció: | Современная ревматология |
| Matèries: | |
| Accés en línia: | https://mrj.ima-press.net/mrj/article/view/1651 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|